International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis

Journal of Hepatology

Volumn 31, Issue 5, 1999, Pages 929-938

  Alvarez, F ^a   Berg, P A ^a   Bianchi, F B ^a   Bianchi, L ^a   Burroughs, A K ^a   Cancado, E L ^a   Chapman, R W ^a   Cooksley, W G E ^a   Czaja, A J ^a   Desmet, V J ^a   Donaldson, P T ^a   Eddleston, A L W F ^a   Fainboim, L ^a   Heathcote, J ^a   Homberg, J C ^a   Hoofnagle, J H ^a   Kakumu, S ^a   Krawitt, E L ^a   Mackay, I R ^a   MacSween, R N M ^a   Maddrey, W C ^a   Manns, M P ^a   McFarlane, I G ^a   Meyer Zum Buschenfelde K H ^a   Mieli Vergani, G ^a   Nakanuma, Y ^a   Nishioka, M ^a   Penner, E ^a   Porta, G ^a   Portmann, B C ^a   Reed, W D ^a   Rodes, J ^a   Schalm, S W ^a   Scheuer, P J ^a   Schrumpf, E ^a   Seki, T ^a   Toda, G ^a   Tsuji, T ^a   Tygstrup, N ^a   Vergani, D ^a   Zeniya, M ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN G; LIVER ENZYME; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; CHOLESTATIC HEPATITIS; DISEASE ASSOCIATION; HEPATITIS C VIRUS; HYPERGAMMAGLOBULINEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIVER HISTOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCORING SYSTEM; VIRUS HEPATITIS;

EID: 0032718310     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80297-9     Document Type: Article

References (84)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
2. Ludwig J, McFarlane IG, Rakela J, Demetris AJ, Wanless IR, Chairs Panel. Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: summary of recommendations developed by an international working party. Am J Gastroenterol. 89:1994;S177-S181.
3. Ludwig J, McFarlane IG, Rakela J. Terminology of Chronic Hepatitis: International Working Party. Chairs Panel Am J Gastroenterol. 90:1995;181-189.
4. Johnson PJ, McFarlane IG. Meeting Report: International Autoimmune Hepatitis Group. Hepatology. 18:1993;998-1005.
5. Czaja AJ, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci. 41:1996;305-314.
6. Bianchi FB, Cassani F, Lenzi M, Ballardini G, Muratori L, Giostra F, et al. Impact of International Autoimmune Hepatitis Group scoring system in definition of autoimmune hepatitis. An Italian experience. Dig Dis Sci. 41:1996;166-171.
7. Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, et al. Present status of autoimmune hepatitis in Japan - correlating the characteristics with international criteria in an area with a high rate of HCV infection. J Hepatol. 26:1997;1207-1212.
8. Miyakawa H, Kitazawa E, Abe K, Kawaguchi N, Fuzikawa H, Kikuchi K, et al. Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis. J Gastroenterol. 32:1997;769-776.
9. Dickson RC, Gaffey MJ, Ishitani MB, Roarty TP, Driscoll CJ, Caldwell SH. The international autoimmune hepatitis score in chronic hepatitis C. J Viral Hep. 4:1997;121-128.
10. Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology. 23:1996;1369-1376.
11. Czaja AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis. 4:1984;1-12.
12. Nishioka M, Morshed SA. Recent progress in autoimmune liver disease. Husband AJ. Advances in Mucosal Immunology, vol. 1. 1997;425-437 University of Sydney Press, Sydney.
13. Herzog D, Rasquin-Weber AM, Debray D, Alvarez F. Subfulminant hepatic failure in autoimmune hepatitis type 1: an unusual form of presentation. J Hepatol. 27:1997;578-582.
14. Parker DR, Kingham JGC. Type 1 autoimmune hepatitis is primarily a disease of later life. Q J Med. 90:1997;289-296.
15. Gordon SC. Diagnostic criteria, clinical manifestations and natural history of autoimmune hepatitis. Krawitt EL, Wiesner RH, Nishioka M. Autoimmune Liver Diseases. 2nd ed. 1998;343-360 Elsevier, Amsterdam.
16. McFarlane IG. The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut. 42:1998;599-602.
17. Kooy A, de Heide LJM, Engelkens HJH, Mulder AH, van Hagen M, Schalm SW. How to diagnose autoimmune hepatitis in systemic lupus erythematosus. Hepatology. 23:1996;937-938.
18. Snook JA, Chapman RW, Fleming K, Jewell DP. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol. 76:1989;30-33.
19. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut. 33:1992;657-662.
20. Hardarson S, La Brecque DR, Mitros FA, Neil GA, Goeken JA. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases: high prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis. Clin Microbiol Immunol. 99:1993;277-281.
21. Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CGM. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver disease. Hepatology. 17:1993;411-417.
22. Vidrich A, Lee J, James E, Cobb L, Targan S. Segregation of pANCA antigenic recognition by Dnase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis and primary sclerosing cholangitis. J Clin Immunol. 15:1995;293-299.
23. Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology. 108:1995;1159-1166.
24. Zauli D, Ghetti S, Grassi A, Descovich C, Cassani F, Ballardini G, et al. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology. 25:1997;1105-1107.
25. Toh BH. Anti-cytoskeletal autoantibodies: diagnostic significance for liver diseases, infections and systemic autoimmune diseases. Autoimmunity. 11:1991;119-125.
26. Worman HJ, Courvalin JC. Autoantibodies against nuclear envelope proteins in liver disease. Hepatology. 14:1991;1269-1279.
27. Takaki A, Sakaguchi K, Ogawa S, Kawamoto H, Tsuji T. Specificities and clinical significance of anti-cytoskeleton antibodies in anti-smooth muscle antibody-positive patients with chronic liver disease. Acta Med Okayama. 48:1994;143-149.
28. Kallenberg CGM, Brouwer E, Weening JJ, Tervaert JWC. Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney International. 46:1994;1-15.
29. Wesierska-Gadek J, Penner E. Nuclear antigens. McFarlane IG, Williams R. Molecular Basis of Autoimmune Hepatitis. 1996;24-44 RG Landes, Austin, Texas.
30. Stoffel MP, Csernok E, Herzberg C, Johnston T, Carroll SF, Gross WL. Anti-neutrophil cytoplasmic (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol. 104:1996;54-59.
31. Zauli D, Cassani F, Bianchi FB. Cytoskeletal antigens. McFarlane IG, Williams R. Molecular Basis of Autoimmune Hepatitis. 1996;45-58 RG Landes, Austin, Texas.
32. Manns MP. Cytoplasmic antigens. McFarlane IG, Williams R. Molecular Basis of Autoimmune Hepatitis. 1996;59-74 RG Landes, Austin, Texas.
33. Terjung B, Herzog V, Worman HJ, Gestmann I, Bauer C, Sauerbruch T, et al. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology. 28:1998;332-340.
34. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci. 42:1997;1688-1696.
35. Chen M, Shirai M, Czaja AJ, Kurokohchi K, Arachi T, Arima K, et al. Characterisation of anti-histone antibodies in patients with type 1 autoimmune hepatitis. J Gastroenterol Hepatol. 199:1998;483-489.
36. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology. 24:1996;1068-1073.
37. Cancado EL, Vilas-Boas LS, Abrantes-Lemos CP, Novo NF, Porta G, Da Silva LC, et al. Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture. Hepatology. 23:1996;1098-1104.
38. Treichel U, McFarlane BM, Seki T, Krawitt El Alessi N, Stickel F, et al. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology. 107:1994;799-804.
39. McFarlane BM. Hepatocellular membrane antigens. McFarlane IG, Williams R. The Molecular Basis of Autoimmune Hepatitis. 1996;75-104 RG Landes, Austin, Texas.
40. Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology. 105:1993;1522-1528.
41. Abuaf N, Johanet C, Chretien P, Martini E, Soulier E, Laperche S, et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology. 16:1992;892-898.
42. Han S, Tredger M, Gregorio GV, Mieli-Vergani G, Vergani D. Antiliver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology. 21:1995;58-62.
43. Lenzi M, Manotti P, Muratori L, Cataleta M, Ballardini G, Cassani F, et al. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut. 36:1995;749-754.
44. Muratori L, Cataleta M, Muratori P, Lenzi M, Bianchi FB. Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis. Gut. 42:1998;721-726.
45. Stechemesser E, Klein R, Berg PA. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology. 18:1993;1-9.
46. Toda G, Ikeda Y, Kashiwagi M, Iwamori M, Oka H. Hepatocyte plasma membrane glycosphingolipid reactive with sera from patients with autoimmune chronic active hepatitis: its identification as sulfatide. Hepatology. 12:1990;664-670.
47. Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology. 25:1997;541-547.
48. Maddrey WC. How many types of autoimmune hepatitis are there? Gastroenterology. 105:1993;1571-1574.
49. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
50. Heringlake S, Tillman HL, Cordes-Temme P, Trautwein C, Hunsmann G, Manns MP. GBV-C/HGV is not the major cause of autoimmune hepatitis. J Hepatol. 25:1996;980-984.
51. Gerken G. Distinction between autoimmune and viral liver diseases. Berg P, Lohse AW, Tiegs G, Wendel A. Autoimmune Liver Disease. 1997;86-92 Kluwer, London.
52. Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocylcine induced autoimmune hepatitis and systemic lupus erythematosuslike syndrome. Br Med J. 312:1996;169-172.
53. Malcolm A, Heap TR, Eckstein RP, Lunzer MR. Minocycline induced liver injury. Am J Gastroenterol. 91:1996;1641-1643.
54. Goldstein PE, Devier J, Cremer M. Acute hepatitis and drug-related lupus induced by minocycline treatment. Am J Gastroenterol. 91:1997;143-146.
55. Colombato LA, Alvarez F, Côté J, Huet MP. Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology. 107:1994;1839-1843.
56. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology. 108:1995;157-164.
57. Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on disease profile. Hepatology. 26:1997;561-566.
58. Calleja JL, Albillos A, Cacho G, Abreu L, Esartin P. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. J Hepatol. 24:1996;308-312.
59. Gregorio GV, Jones H, Choudhuri K, Vegnente A, Bortolotti F, Mieli-Vergani G, et al. Autoantibody prevalence in chronic hepatitis B virus infection: effect of interferon alpha. Hepatology. 24:1996;520-523.
60. Dalekos GN, Wedemeyer H, Obermayer-Straub P, Kayser A, Barut A, Frank H, et al. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during α-interferon therapy. J Hepatol. 30:1999;366-375.
61. Goodman ZD, McNally PR, Davis DR, Ishak KG. Autoimmune cholangitis. A variant of primary biliary cirrhosis: clinicopathological and serologic correlations in 200 cases. Dig Dis Sci. 40:1995;1232-1242.
62. Inverizzi P, Crosignani A, Battezzati PM, Covini G, De Valle G, Larghi A, et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology. 25:1997;1090-1095.
63. Michieletti P, Wanless IR, Katz A, Scheuer P, Yeaman S, Bassendine M, et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct clinical syndrome of autoimmune cholangitis. Gut. 35:1994;260-265.
64. Kim WR, Poterucha JJ, Jorgensen RA, Batts KP, Homburger HA, Dickson ER, et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology. 26:1997;22-26.
65. Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K, et al. Autoimmune cholangitis and primary biliary cirrhosis - an autoimmune enigma. Liver. 19:1999;122-128.
66. Heathcote J. Overlap syndromes of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis. Krawitt EL, Wiesner RH, Nishioka M. Autoimmune Liver Diseases, 2nd ed. 1998;449-456 Elsevier, Amsterdam.
67. Neuberger J, Thomson R. PBC and AMA - what is the connection? Hepatology. 29:1999;271-276.
68. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology. 18:1993;10-15.
69. Mitchison HC, Palmer JM, Bassendine MF, Watson AJ, Record CO, James OFW. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol. 15:1992;336-344.
70. Taylor SL, Dean PJ, Riely CA. Primary autoimmune cholangitis: an alternative to antibmitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol. 18:1994;91-99.
71. Duclos-Valee JC, Hadenque A, Ganne-Carrie N, Robin E, Degott C, Erlinger S. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A. Dig Dis Sci. 40:1995;1069-1073.
72. Metcalf J, Mitchison HC, Palmer JM. Natural history of early primary biliary cirrhosis. Lancet. 348:1996;1399-1402.
73. McNair ANB, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol. 93:1998;777-784.
74. Wilschanski M, Chait P, Wade JA, Davis L, Corey M, St. Louis P, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology. 22:1995;1415-1422.
75. Protzer U, Dienes HP, Bianchi L, Lohse AW, Helmreich-Becker I, Gerken G, et al. Post infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis. Liver. 16:1996;274-282.
76. Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children. Krawitt EL, Wiesner RH, Nishioka M. Autoimmune Liver Diseases, 2nd ed. 1998;425-432 Elsevier, Amsterdam.
77. Roberts EA. Primary sclerosing cholangitis in children. Krawitt EL, Wiesner RH, Nishioka M. Autoimmune Liver Diseases, 2nd ed. 1998;433-447 Elsevier, Amsterdam.
78. Balasubramaniam K, Wiesner RH, LaRusso NF. Primary sclerosing cholangitis with normal alkaline phosphatase activity. Gastroenterology. 95:1988;1395-1398.
79. Rabinowitz M, Demetris AJ, Bou-Abboud CG, Van Thiel DH. Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig Dis Sci. 37:1992;1606-1611.
80. Leggett BA, Hallam A, Powell EE, Powell LW. Autoimmune chronic active hepatitis evolving to primary sclerosing cholangitis: evidence for a common pathogenesis. [abstract] Hepatology. 16:1992;191A.
81. Lawrence SP, Sherman KE, Lawson JM, Goodman ZD. A 39 year old man with chronic hepatitis. Semin Liver Dis. 14:1994;97-105.
82. Wurbs D, Klein R, Terracciano LM, Berg PA, Bianchi L. A 28-year-old woman with a combined hepatitis cholestatic syndrome. Hepatology. 22:1995;1598-1805.
83. Gohlke F, Lohse AW, Dienes HP, Löhr H, Märker-Hermann E, Gerken G, et al. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol. 24:1996;699-705.
84. Roberts S, Poterucha JJ, Gores GJ, Czaja AJ. Overlap between type 1 autoimmune hepatitis and primary sclerosing cholangitis. [abstract] Hepatology. 22:1995;129A.